Turning Point Therapeutics Inc. (TPTX) PT Raised to $68 at SVB Leerink, After Collaboration Deal Announced
Tweet Send to a Friend
SVB Leerink analyst Andrew S. Berens raised the price target on Turning Point Therapeutics Inc. (NASDAQ: TPTX) to $68.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
